On December 19, 2011, Merus Labs International Inc. (“Merus”) and Envoy Capital Group Inc. (“Envoy”) completed their amalgamation, which formed “Merus Labs International Inc.” trading on the Toronto Stock Exchange under symbol, “MLS”. In connection with the amalgamation, Envoy closed a private placement of 4,196,500 units of Envoy at a price per Envoy unit of CDN $2.00 for total gross proceeds of $8,393,000.

Merus is a specialty pharmaceutical company engaged in the acquisition and licensing of pharmaceutical products. Merus Labs utilizes its expertise in the North American pharmaceutical markets and its access to capital to acquire and license niche branded products in Canada and United States. Merus Labs further enhances the sale and distribution of these products by introduction of a focused marketing and promotion plan.

Peterson Law acted for Envoy with a team that included Dennis Peterson, Steven Agnew and David Gardos.